Institutional Analyst Inc. has initiated coverage of Vystar Corp., (VYST), with a report in “Biotech Stock Review” detailing the market opportunity for Vystar as the exclusive creator and licensor of breakthrough patented processes that remove virtually all proteins and non-rubbers that cause latex allergies and odor from latex to create Vytex ® natural rubber latex (NRL) that can be used in over 40,000 products.